Cargando…

Review of Under-Recognized Adjunctive Therapies for Cancer

SIMPLE SUMMARY: This review presents cancer and primary care providers with an overview of underappreciated adjunctive measures that may improve their patients’ quality of life and survival. This is not a comprehensive review but adjunctive recommendations which may be easily addressed by the provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Money, Mary E., Matthews, Carolyn M., Tan-Shalaby, Jocelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563303/
https://www.ncbi.nlm.nih.gov/pubmed/36230703
http://dx.doi.org/10.3390/cancers14194780
_version_ 1784808371020365824
author Money, Mary E.
Matthews, Carolyn M.
Tan-Shalaby, Jocelyn
author_facet Money, Mary E.
Matthews, Carolyn M.
Tan-Shalaby, Jocelyn
author_sort Money, Mary E.
collection PubMed
description SIMPLE SUMMARY: This review presents cancer and primary care providers with an overview of underappreciated adjunctive measures that may improve their patients’ quality of life and survival. This is not a comprehensive review but adjunctive recommendations which may be easily addressed by the provider and acceptable to the cancer patient. These include exercise, diet, stress-reduction techniques, recognition and management of sleep problems, advice on smoking cessation, and use of selective nutraceuticals and pharmaceuticals as adjuvants. In addition, patients may be more compliant if suggestions and referrals are made by their trusted providers. ABSTRACT: Patients and providers may not be aware that several adjunctive measures can significantly improve the quality of life, response to treatment, and possibly outcomes for cancer patients. This manuscript presents a review of practical under-recognized adjunctive therapies that are effective including exercise; stress-reduction techniques such as mindfulness, massage, yoga, Tai Chi, breathing exercises; importance of sleep quality; diet modifications such as calorie restriction at the time of chemotherapy and avoidance of high carbohydrate foods; supplements such as aspirin, green tea, turmeric, and melatonin; and repurposed prescription medications such as metformin and statins. Each recommendation should be tailored to the individual patient to assure no contraindications.
format Online
Article
Text
id pubmed-9563303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95633032022-10-15 Review of Under-Recognized Adjunctive Therapies for Cancer Money, Mary E. Matthews, Carolyn M. Tan-Shalaby, Jocelyn Cancers (Basel) Review SIMPLE SUMMARY: This review presents cancer and primary care providers with an overview of underappreciated adjunctive measures that may improve their patients’ quality of life and survival. This is not a comprehensive review but adjunctive recommendations which may be easily addressed by the provider and acceptable to the cancer patient. These include exercise, diet, stress-reduction techniques, recognition and management of sleep problems, advice on smoking cessation, and use of selective nutraceuticals and pharmaceuticals as adjuvants. In addition, patients may be more compliant if suggestions and referrals are made by their trusted providers. ABSTRACT: Patients and providers may not be aware that several adjunctive measures can significantly improve the quality of life, response to treatment, and possibly outcomes for cancer patients. This manuscript presents a review of practical under-recognized adjunctive therapies that are effective including exercise; stress-reduction techniques such as mindfulness, massage, yoga, Tai Chi, breathing exercises; importance of sleep quality; diet modifications such as calorie restriction at the time of chemotherapy and avoidance of high carbohydrate foods; supplements such as aspirin, green tea, turmeric, and melatonin; and repurposed prescription medications such as metformin and statins. Each recommendation should be tailored to the individual patient to assure no contraindications. MDPI 2022-09-29 /pmc/articles/PMC9563303/ /pubmed/36230703 http://dx.doi.org/10.3390/cancers14194780 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Money, Mary E.
Matthews, Carolyn M.
Tan-Shalaby, Jocelyn
Review of Under-Recognized Adjunctive Therapies for Cancer
title Review of Under-Recognized Adjunctive Therapies for Cancer
title_full Review of Under-Recognized Adjunctive Therapies for Cancer
title_fullStr Review of Under-Recognized Adjunctive Therapies for Cancer
title_full_unstemmed Review of Under-Recognized Adjunctive Therapies for Cancer
title_short Review of Under-Recognized Adjunctive Therapies for Cancer
title_sort review of under-recognized adjunctive therapies for cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563303/
https://www.ncbi.nlm.nih.gov/pubmed/36230703
http://dx.doi.org/10.3390/cancers14194780
work_keys_str_mv AT moneymarye reviewofunderrecognizedadjunctivetherapiesforcancer
AT matthewscarolynm reviewofunderrecognizedadjunctivetherapiesforcancer
AT tanshalabyjocelyn reviewofunderrecognizedadjunctivetherapiesforcancer